Predicine
Shidong Jia is the current CEO at Predicine. Prior to this, they were the editor-in-chief for the Journal of Circulating Biomarkers from January 2014 to December 2018. Shidong's work with the journal aimed to engage international levels in translational art for the study of exosomes and microvesicles, circulating tumor cells, cell-free circulating DNA, and circulating protein and lipid markers in precision medicine and clinical drug development. From January 2010 to December 2015, they were a Scientist and Biomarker Team Lead at Genentech. And finally, from January 2010 to December 2010, they were Laboratory Head at Novartis.
Shidong Jia received their M.D. from Harbin Medical University and their Ph.D. from Peking Union Medical College. Shidong is currently a postdoctoral fellow at the Dana-Farber Cancer Institute and Harvard Medical School.
Some direct reports include Dennis Merkle - President, Pan Du - President.
This person is not in any offices
Predicine
Predicine, a molecular information company based in Silicon Valley, has developed a portfolio of regulated liquid biopsy genomic products to help advance the science of precision medicine in cancer.